Eternal Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 06-12-2024
- Paid Up Capital ₹ 0.10 M
as on 06-12-2024
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 20.89%
(FY 2022)
- Profit -181.81%
(FY 2022)
- Ebitda 39.18%
(FY 2022)
- Net Worth -309.85%
(FY 2022)
- Total Assets -26.48%
(FY 2022)
About Eternal Lifesciences
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Manoj Bhavrilal, Alkesh Chopda, and Sonali Chopda serve as directors at the Company.
- CIN/LLPIN
U51909MH2020PTC343005
- Company No.
343005
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Jul 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Eternal Lifesciences?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sonali Chopda | Director | 29-Mar-2023 | Current |
Manoj Bhavrilal | Director | 31-Jul-2020 | Current |
Alkesh Chopda | Director | 31-Jul-2020 | Current |
Financial Performance of Eternal Lifesciences.
Eternal Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 20.89% increase. The company also saw a substantial fall in profitability, with a 181.81% decrease in profit. The company's net worth observed a substantial decline by a decrease of 309.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Eternal Lifesciences?
Unlock access to Eternal Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Medezzy Pharmacy Private LimitedActive 4 years 3 months
Manoj Bhavrilal, Alkesh Chopda and 1 more are mutual person
- Magnum Pharma And Diagnostic Services Private LimitedActive 10 years 10 months
Alkesh Chopda and Sonali Chopda are mutual person
- Chopda Medicare And Research Centre Private LimitedActive 29 years 10 months
Manoj Bhavrilal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Eternal Lifesciences?
Eternal Lifesciences has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eternal Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eternal Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.